Moore Capital Management’s Aclaris Therapeutics ACRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-40,000	Closed	-$1.03M	–	228
2017 Q3	$1.03M	Sell	40,000 -10,000	-20%	-$258K	0.02%	169
2017 Q2	$1.36M	Sell	50,000 -12,500	-20%	-$339K	0.04%	130
2017 Q1	$1.86M	Buy	+62,500	New	+$1.86M	0.05%	131